CHAD2DS2-VASc score ≤ 2 (n = 80) | CHAD2DS2-VASc score ≥ 3 (n = 58) | P value | |
---|---|---|---|
Median total mapping points per patient | 1277 [789–1953] | 1320 [995–1862] | 0.85 |
Median and regional bipolar voltage amplitude, mV | |||
Global left atrium | 2.25 (1.49–2.79) | 1.49 (1.1–2.48) | 0.02 |
Anterior | 1.97 (1.29–2.67) | 1.39 (0.87–1.93) | < 0.01 |
Posterior | 1.69 (1.02–2.34) | 1.2 (0.86–2.04) | 0.06 |
Inferior | 2.28 (1.42–3.07) | 1.59 (0.96–2.68) | 0.02 |
Lateral | 1.99 (1.14–2.57) | 1.69 (1.12–2.64) | 0.56 |
Left Atrial Appendage | 2.23 (1.25–3.05) | 2.1 (1.18–2.86) | 0.7 |
LVZ extent calculated as the percentage of LA surface area | |||
No LVZ, n (%) | 66 (82.5%) | 35 (60.34%) | < 0.01 |
LVZ, n (%) | 14 (17.5%) | 23 (39.66%) | < 0.01 |
Mild LVZ, n (%) | 5 (6.33%) | 11 (18.97%) | 0.04 |
Moderate LVZ, n (%) | 7 (8.86%) | 5 (8.62%) | 1 |
Severe LVZ, n (%) | 2 (2.53%) | 7 (12.07%) | 0.04 |
Number of regional LVZs, n (%) | |||
Anterior | 16 (20.25%) | 24 (41.38%) | 0.01 |
Septal | 18 (22.78%) | 18 (31.03%) | 0.37 |
Posterior | 8 (10.13%) | 12 (20.69%) | 0.14 |
Inferior | 1 (1.27%) | 7 (12.07%) | 0.01 |
Lateral | 1 (1.27%) | 3 (5.17%) | 0.31 |
LAA | 0 (0%) | 6 (10.34%) | < 0.01 |